HOME > 홍보/투자정보 > IR 자료실
전체
IR 자료
IR 리포트
IR 레터
2017-06-14 ViroMed
[Nomura증권] VM202 aims for ALS treatment
2017-05-24 ViroMed
[Nomura증권] Potential blockbuster well on track (report)
2017-04-06 ViroMed
[Citi증권] Expediting Ph3 Trial Enrollment in DPN Indication
2017-01-19 ViroMed
[Citi증권] Alert: Improving Bargaining Power and Broadening Interest Base on VM202
2017-01-05 ViroMed
[Citi증권] Buy (1H): Turning Conservative on Ph3 Trial Timeline, But Remain Constr
1 2 3 4 5 6 7 8 9 10